Position in SNDX
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$726,519
+$311,530 QoQ
Shares Held
31,101
+57.5% QoQ
Ownership
0.035%
of shares outstanding
% of Portfolio
0.18%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Sep 2024
4 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in SNDX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Bridgefront Capital, LLC holds $16,132,916 across 33 Biotechnology names. SNDX ranks #8 (4.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | RPRX |
Royalty Pharma plc
|
48,362 | $2,319,925 | |
| 2 | RYTM |
Rhythm Pharmaceuticals, Inc.
|
12,495 | $1,086,690 | |
| 3 | CGON |
CG Oncology, Inc.
|
14,401 | $974,659 | |
| 4 | BEAM |
Beam Therapeutics Inc.
|
34,018 | $810,648 | |
| 5 | ADMA |
Adma Biologics, Inc.
|
88,318 | $795,745 | |
| 6 | RARE |
Ultragenyx Pharmaceutical Inc.
|
35,135 | $736,078 | |
| 7 | RVMD |
Revolution Medicines, Inc.
|
7,515 | $730,833 | |
| 8 | SNDX |
Syndax Pharmaceuticals Inc
This page
|
31,101 | $726,519 |
All Filings in SNDX
Export CSV
4 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $726,519 | 31,101 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $414,989 | 19,752 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $336,131 | 21,848 | Shares | Sole | 2025-11-14 | |
| 2024-09-30 | $391,660 | 20,346 | Shares | Sole | 2024-11-14 | |
| No filing history on record for this holder in this stock. | ||||||